Abstract
Poor adherence and persistence can have a major negative impact on the long-term clinical effectiveness of recombinant human growth hormone (r-hGH) treatment. However, real-time monitoring of adherence and persistence can be difficult. The easypod™ injection device is an electronic auto-injector for r-hGH (Saizen®, Merck Serono S.A. – Geneva, Switzerland) that includes an automatic memory feature for monitoring injection dose history. The easypod™ device records the dose of r-hGH injected, as well as the time and date of each injection. The cumulative dose history can be viewed on the screen of the easypod™ device as a calendar or by individual entry per injection. Based on a pre-programmed dosing schedule, missed or incomplete doses are displayed. The easypod™ connection kit allows uploading of the dose history to a secure online database, subsequently enabling the physician or nurse, using a personal computer, to view and print graphical and schematic data displays, use the data for calculations and export to other computing programmes. easypod™ is the first r-hGH injection device to enable accurate monitoring of treatment adherence and persistence, thereby providing an essential tool for optimizing r-hGH treatment outcome.
Keywords: Adherence, administration, electronic auto-injector, growth hormone, injection device, recombinant, persistence, recombinant human growth hormone, easypodTM injection, Turner syndrome
Current Drug Therapy
Title: Electronic Recording of Growth Hormone Dosing History: The Easypod™ Auto-Injector
Volume: 5 Issue: 4
Author(s): Francois-Xavier Lion
Affiliation:
Keywords: Adherence, administration, electronic auto-injector, growth hormone, injection device, recombinant, persistence, recombinant human growth hormone, easypodTM injection, Turner syndrome
Abstract: Poor adherence and persistence can have a major negative impact on the long-term clinical effectiveness of recombinant human growth hormone (r-hGH) treatment. However, real-time monitoring of adherence and persistence can be difficult. The easypod™ injection device is an electronic auto-injector for r-hGH (Saizen®, Merck Serono S.A. – Geneva, Switzerland) that includes an automatic memory feature for monitoring injection dose history. The easypod™ device records the dose of r-hGH injected, as well as the time and date of each injection. The cumulative dose history can be viewed on the screen of the easypod™ device as a calendar or by individual entry per injection. Based on a pre-programmed dosing schedule, missed or incomplete doses are displayed. The easypod™ connection kit allows uploading of the dose history to a secure online database, subsequently enabling the physician or nurse, using a personal computer, to view and print graphical and schematic data displays, use the data for calculations and export to other computing programmes. easypod™ is the first r-hGH injection device to enable accurate monitoring of treatment adherence and persistence, thereby providing an essential tool for optimizing r-hGH treatment outcome.
Export Options
About this article
Cite this article as:
Lion Francois-Xavier, Electronic Recording of Growth Hormone Dosing History: The Easypod™ Auto-Injector, Current Drug Therapy 2010; 5 (4) . https://dx.doi.org/10.2174/157488510792927474
DOI https://dx.doi.org/10.2174/157488510792927474 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Approaching Inherited Disease on a Genomic Scale
Current Genomics Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease
Current Topics in Medicinal Chemistry Anticancer Drugs Designed by Mother Nature: Ancient Drugs but Modern Targets
Current Pharmaceutical Design Modulation of Integrin-binding Selectivity by Mutation within the RGDLoop of Snake Venom Proteins: A Novel Drug Development Approach
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Different Concepts of Drug Delivery in Disease Entities
Mini-Reviews in Medicinal Chemistry An Update on Hepatic Stem Cells: Bench to Bedside
Current Pharmaceutical Biotechnology Experimental Research on Nitric Oxide and the Therapy of Alzheimer Disease: A Challenging Bridge
CNS & Neurological Disorders - Drug Targets A Partial Failure of Membrane Protein Turnover May Cause Alzheimers Disease: A New Hypothesis
Current Alzheimer Research Vascular Endothelial Growth Factor Receptors [VEGFR] as Target in Breast Cancer Treatment: Current Status in Preclinical and Clinical Studies and Future Directions
Current Topics in Medicinal Chemistry Role of Bactericidal/Permeability-Increasing Protein (BPI) in Sepsis and Liver Cirrhosis, and Its Clinical Implications
Anti-Infective Agents Searching for Phytoinsulins as Cardiovascular Protector in Metabolic Syndrome
Current Pharmaceutical Design Nontoxic-dose of Deguelin Induce NPMc+ AML Cell Differentiation by Selectively Targeting Mt NPM1/SIRT1 Instead of HDAC1/3
Current Cancer Drug Targets Regulation of B Cell Activation by PECAM-1: Implications for the Development of Autoimmune Disorders
Current Pharmaceutical Design The Economic Costs for the Control of Cardiovascular Risk: An Overview
Current Pharmaceutical Design Association Between Total Bilirubin Levels and Cardio-Metabolic Risk Factors Related to Obesity
Endocrine, Metabolic & Immune Disorders - Drug Targets Treatments for Obesity-Related Hypertension
Current Hypertension Reviews Potential Roles of Eosinophils in Cancer Therapy: Epidemiological Studies, Experimental Models, and Clinical Pathology
Recent Patents on Anti-Cancer Drug Discovery T Cell Polarization and the Formation of Immunological Synapses: From Antigen Recognition to Virus Spread
Current Immunology Reviews (Discontinued) Nitric Oxide Homeostasis in Neurodegenerative Diseases
Current Alzheimer Research Role of the Gut Microbiota in Age-Related Chronic Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets